112 related articles for article (PubMed ID: 22491792)
1. Cost-effectiveness analysis of autologous chondrocyte implantation: a comparison of periosteal patch versus type I/III collagen membrane.
Samuelson EM; Brown DE
Am J Sports Med; 2012 Jun; 40(6):1252-8. PubMed ID: 22491792
[TBL] [Abstract][Full Text] [Related]
2. A prospective, randomised study comparing two techniques of autologous chondrocyte implantation for osteochondral defects in the knee: Periosteum covered versus type I/III collagen covered.
Gooding CR; Bartlett W; Bentley G; Skinner JA; Carrington R; Flanagan A
Knee; 2006 Jun; 13(3):203-10. PubMed ID: 16644224
[TBL] [Abstract][Full Text] [Related]
3. The incidence and clinical relevance of graft hypertrophy after matrix-based autologous chondrocyte implantation.
Pietschmann MF; Niethammer TR; Horng A; Gülecyüz MF; Feist-Pagenstert I; Jansson V; Müller PE
Am J Sports Med; 2012 Jan; 40(1):68-74. PubMed ID: 22031857
[TBL] [Abstract][Full Text] [Related]
4. Autologous chondrocyte implantation versus ACI using 3D-bioresorbable graft for the treatment of large full-thickness cartilage lesions of the knee.
Erggelet C; Kreuz PC; Mrosek EH; Schagemann JC; Lahm A; Ducommun PP; Ossendorf C
Arch Orthop Trauma Surg; 2010 Aug; 130(8):957-64. PubMed ID: 19711090
[TBL] [Abstract][Full Text] [Related]
5. Characteristic complications after autologous chondrocyte implantation for cartilage defects of the knee joint.
Niemeyer P; Pestka JM; Kreuz PC; Erggelet C; Schmal H; Suedkamp NP; Steinwachs M
Am J Sports Med; 2008 Nov; 36(11):2091-9. PubMed ID: 18801942
[TBL] [Abstract][Full Text] [Related]
6. Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study.
Bartlett W; Skinner JA; Gooding CR; Carrington RW; Flanagan AM; Briggs TW; Bentley G
J Bone Joint Surg Br; 2005 May; 87(5):640-5. PubMed ID: 15855365
[TBL] [Abstract][Full Text] [Related]
7. Chondrocyte implantation in the repair of chondral lesions of the knee: economics and quality of life.
Minas T
Am J Orthop (Belle Mead NJ); 1998 Nov; 27(11):739-44. PubMed ID: 9839958
[TBL] [Abstract][Full Text] [Related]
8. Autologous chondrocyte implantation in chondral defects of the knee with a type I/III collagen membrane: a prospective study with a 3-year follow-up.
Steinwachs M; Kreuz PC
Arthroscopy; 2007 Apr; 23(4):381-7. PubMed ID: 17418330
[TBL] [Abstract][Full Text] [Related]
9. Autologous chondrocyte implantation: natural history of postimplantation periosteal hypertrophy and effects of repair-site debridement on outcome.
Henderson I; Gui J; Lavigne P
Arthroscopy; 2006 Dec; 22(12):1318-1324.e1. PubMed ID: 17157731
[TBL] [Abstract][Full Text] [Related]
10. Clinical and cost-effectiveness of autologous chondrocyte implantation for cartilage defects in knee joints: systematic review and economic evaluation.
Clar C; Cummins E; McIntyre L; Thomas S; Lamb J; Bain L; Jobanputra P; Waugh N
Health Technol Assess; 2005 Dec; 9(47):iii-iv, ix-x, 1-82. PubMed ID: 16336842
[TBL] [Abstract][Full Text] [Related]
11. Autologous Chondrocyte Implantation With Collagen Membrane.
Gillogly SD; Wheeler KS
Sports Med Arthrosc Rev; 2015 Sep; 23(3):118-24. PubMed ID: 26225570
[TBL] [Abstract][Full Text] [Related]
12. Autologous chondrocyte implantation with collagen bioscaffold for the treatment of osteochondral defects in rabbits.
Willers C; Chen J; Wood D; Xu J; Zheng MH
Tissue Eng; 2005; 11(7-8):1065-76. PubMed ID: 16144442
[TBL] [Abstract][Full Text] [Related]
13. Use of a type I/III bilayer collagen membrane decreases reoperation rates for symptomatic hypertrophy after autologous chondrocyte implantation.
Gomoll AH; Probst C; Farr J; Cole BJ; Minas T
Am J Sports Med; 2009 Nov; 37 Suppl 1():20S-23S. PubMed ID: 19841142
[TBL] [Abstract][Full Text] [Related]
14. Autologous chondrocyte implantation for treatment of cartilage defects of the knee: what predicts the need for reintervention?
Jungmann PM; Salzmann GM; Schmal H; Pestka JM; Südkamp NP; Niemeyer P
Am J Sports Med; 2012 Jan; 40(1):58-67. PubMed ID: 21969180
[TBL] [Abstract][Full Text] [Related]
15. [Evidence-based therapy for cartilage lesions in the knee - regenerative treatment options].
Proffen B; von Keudell A; Vavken P
Z Orthop Unfall; 2012 Jun; 150(3):280-9. PubMed ID: 22723070
[TBL] [Abstract][Full Text] [Related]
16. A prospective multicenter study on the outcome of type I collagen hydrogel-based autologous chondrocyte implantation (CaReS) for the repair of articular cartilage defects in the knee.
Schneider U; Rackwitz L; Andereya S; Siebenlist S; Fensky F; Reichert J; Löer I; Barthel T; Rudert M; Nöth U
Am J Sports Med; 2011 Dec; 39(12):2558-65. PubMed ID: 21984690
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of autologous chondrocyte implantation in patients with failed prior treatment for articular cartilage defect of the knee: results of the Study of the Treatment of Articular Repair (STAR) clinical trial.
Zaslav K; Cole B; Brewster R; DeBerardino T; Farr J; Fowler P; Nissen C;
Am J Sports Med; 2009 Jan; 37(1):42-55. PubMed ID: 18927254
[TBL] [Abstract][Full Text] [Related]
18. Histologic and immunohistochemical characteristics of failed articular cartilage resurfacing procedures for osteochondritis of the knee: a case series.
LaPrade RF; Bursch LS; Olson EJ; Havlas V; Carlson CS
Am J Sports Med; 2008 Feb; 36(2):360-8. PubMed ID: 18006675
[TBL] [Abstract][Full Text] [Related]
19. A histological comparison of the repair tissue formed when using either Chondrogide(®) or periosteum during autologous chondrocyte implantation.
McCarthy HS; Roberts S
Osteoarthritis Cartilage; 2013 Dec; 21(12):2048-57. PubMed ID: 24161708
[TBL] [Abstract][Full Text] [Related]
20. Autologous chondrocyte implantation drives early chondrogenesis and organized repair in extensive full- and partial-thickness cartilage defects in an equine model.
Nixon AJ; Begum L; Mohammed HO; Huibregtse B; O'Callaghan MM; Matthews GL
J Orthop Res; 2011 Jul; 29(7):1121-30. PubMed ID: 21319216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
